Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor

Muhammad Rafehi, Alexander Neumann, Younis Baqi, Enas M. Malik, Michael Wiese, Vigneshwaran Namasivayam, Christa E. Müller

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A homology model of the nucleotide-activated P2Y2R was created based on the X-ray structures of the P2Y1 receptor. Docking studies were performed, and receptor mutants were created to probe the identified binding interactions. Mutation of residues predicted to interact with the ribose (Arg110) and the phosphates of the nucleotide agonists (Arg265, Arg292) or that contribute indirectly to binding (Tyr288) abolished activity. The Y114F, R194A, and F261A mutations led to inactivity of diadenosine tetraphosphate and to a reduced response of UTP. Significant reduction in agonist potency was observed for all other receptor mutants (Phe111, His184, Ser193, Phe261, Tyr268, Tyr269) predicted to be involved in agonist recognition. An ionic lock between Asp185 and Arg292 that is probably involved in receptor activation interacts with the phosphate groups. The antagonist AR-C118925 and anthraquinones likely bind to the orthosteric site. The updated homology models will be useful for virtual screening and drug design.

Original languageEnglish
Pages (from-to)8425-8440
Number of pages16
JournalJournal of Medicinal Chemistry
Volume60
Issue number20
DOIs
Publication statusPublished - Oct 26 2017

Fingerprint

Purinergic P2Y2 Receptors
G-Protein-Coupled Receptors
Nucleotides
Purinergic P2Y1 Receptors
Phosphates
Anthraquinones
Mutation
Uridine Triphosphate
Ribose
Drug Design
X-Rays

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor. / Rafehi, Muhammad; Neumann, Alexander; Baqi, Younis; Malik, Enas M.; Wiese, Michael; Namasivayam, Vigneshwaran; Müller, Christa E.

In: Journal of Medicinal Chemistry, Vol. 60, No. 20, 26.10.2017, p. 8425-8440.

Research output: Contribution to journalArticle

Rafehi, Muhammad ; Neumann, Alexander ; Baqi, Younis ; Malik, Enas M. ; Wiese, Michael ; Namasivayam, Vigneshwaran ; Müller, Christa E. / Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor. In: Journal of Medicinal Chemistry. 2017 ; Vol. 60, No. 20. pp. 8425-8440.
@article{0520a5cf683b4705b1a5eb08e4c90ac9,
title = "Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor",
abstract = "A homology model of the nucleotide-activated P2Y2R was created based on the X-ray structures of the P2Y1 receptor. Docking studies were performed, and receptor mutants were created to probe the identified binding interactions. Mutation of residues predicted to interact with the ribose (Arg110) and the phosphates of the nucleotide agonists (Arg265, Arg292) or that contribute indirectly to binding (Tyr288) abolished activity. The Y114F, R194A, and F261A mutations led to inactivity of diadenosine tetraphosphate and to a reduced response of UTP. Significant reduction in agonist potency was observed for all other receptor mutants (Phe111, His184, Ser193, Phe261, Tyr268, Tyr269) predicted to be involved in agonist recognition. An ionic lock between Asp185 and Arg292 that is probably involved in receptor activation interacts with the phosphate groups. The antagonist AR-C118925 and anthraquinones likely bind to the orthosteric site. The updated homology models will be useful for virtual screening and drug design.",
author = "Muhammad Rafehi and Alexander Neumann and Younis Baqi and Malik, {Enas M.} and Michael Wiese and Vigneshwaran Namasivayam and M{\"u}ller, {Christa E.}",
year = "2017",
month = "10",
day = "26",
doi = "10.1021/acs.jmedchem.7b00854",
language = "English",
volume = "60",
pages = "8425--8440",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "20",

}

TY - JOUR

T1 - Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor

AU - Rafehi, Muhammad

AU - Neumann, Alexander

AU - Baqi, Younis

AU - Malik, Enas M.

AU - Wiese, Michael

AU - Namasivayam, Vigneshwaran

AU - Müller, Christa E.

PY - 2017/10/26

Y1 - 2017/10/26

N2 - A homology model of the nucleotide-activated P2Y2R was created based on the X-ray structures of the P2Y1 receptor. Docking studies were performed, and receptor mutants were created to probe the identified binding interactions. Mutation of residues predicted to interact with the ribose (Arg110) and the phosphates of the nucleotide agonists (Arg265, Arg292) or that contribute indirectly to binding (Tyr288) abolished activity. The Y114F, R194A, and F261A mutations led to inactivity of diadenosine tetraphosphate and to a reduced response of UTP. Significant reduction in agonist potency was observed for all other receptor mutants (Phe111, His184, Ser193, Phe261, Tyr268, Tyr269) predicted to be involved in agonist recognition. An ionic lock between Asp185 and Arg292 that is probably involved in receptor activation interacts with the phosphate groups. The antagonist AR-C118925 and anthraquinones likely bind to the orthosteric site. The updated homology models will be useful for virtual screening and drug design.

AB - A homology model of the nucleotide-activated P2Y2R was created based on the X-ray structures of the P2Y1 receptor. Docking studies were performed, and receptor mutants were created to probe the identified binding interactions. Mutation of residues predicted to interact with the ribose (Arg110) and the phosphates of the nucleotide agonists (Arg265, Arg292) or that contribute indirectly to binding (Tyr288) abolished activity. The Y114F, R194A, and F261A mutations led to inactivity of diadenosine tetraphosphate and to a reduced response of UTP. Significant reduction in agonist potency was observed for all other receptor mutants (Phe111, His184, Ser193, Phe261, Tyr268, Tyr269) predicted to be involved in agonist recognition. An ionic lock between Asp185 and Arg292 that is probably involved in receptor activation interacts with the phosphate groups. The antagonist AR-C118925 and anthraquinones likely bind to the orthosteric site. The updated homology models will be useful for virtual screening and drug design.

UR - http://www.scopus.com/inward/record.url?scp=85032439746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032439746&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.7b00854

DO - 10.1021/acs.jmedchem.7b00854

M3 - Article

C2 - 28938069

AN - SCOPUS:85032439746

VL - 60

SP - 8425

EP - 8440

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 20

ER -